25th Mar 2011 11:08
RNS Number : 6423D
AGI Therapeutics plc
25 March 2011
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 24 March 2011 that Irish Life Investment Managers had decreased its shareholding to 4,644,741 Ordinary Shares representing 6.89% of AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai